Decoy Therapeutics (DCOY) EBT Margin (2016 - 2026)
Decoy Therapeutics (DCOY) posted quarterly EBT Margin of 599.23% for Q2 2021, down 44633.0% year-over-year from N/an in Q2 2020, and down 193.29% quarter-over-quarter from 204.31% in Q1 2021.
Decoy Therapeutics (DCOY) EBT Margin (2016 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported EBT Margin for 6 consecutive years, with 599.23% the latest figure, recorded in Q2 2021.
- In Q2 2021, EBT Margin fell 44633.0% year-over-year to 599.23%; the TTM figure through Mar 2022 stood at 3098.46% (down 294926.0% YoY), while the FY2021 annual figure was 1031.83%, down 82880.0% from the prior year.
- EBT Margin fell to 599.23% in Q2 2021 per DCOY's latest filing, from 204.31% in the prior quarter.
- Across five years, EBT Margin topped out at 66.84% in Q3 2018 and bottomed at 12950.17% in Q4 2017.
- Historically, EBT Margin has averaged 1996.09% across 5 years, with a median of 331.77% in 2019.
- On a YoY basis, EBT Margin climbed as much as 1171072 bps in 2018 and fell as far as 246131 bps in 2018.
- Decoy Therapeutics' EBT Margin stood at 12950.17% in 2017, then surged by 90 bps to 1239.45% in 2018, then jumped by 84 bps to 198.53% in 2019, then jumped by 40 bps to 118.96% in 2020, then sank by 404 bps to 599.23% in 2021.
- Business Quant data shows DCOY's EBT Margin at 599.23% in Q2 2021, 204.31% in Q1 2021, and 118.96% in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | -1,142.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,152.11% |
| Jun 30, 2021 | -599.23% |
| Mar 31, 2021 | -204.31% |
| Dec 31, 2020 | -118.96% |
| Sep 30, 2020 | -127.59% |
| Jun 30, 2020 | -152.89% |
| Mar 31, 2020 | -209.44% |
| Dec 31, 2019 | -198.53% |
| Sep 30, 2019 | -429.76% |
| Jun 30, 2019 | -101.82% |
| Mar 31, 2019 | -233.79% |
| Dec 31, 2018 | -1,239.45% |
| Sep 30, 2018 | -66.84% |
| Jun 30, 2018 | -3,725.35% |
| Mar 31, 2018 | -6,327.64% |
| Dec 31, 2017 | -12,950.17% |
| Sep 30, 2017 | -2,451.80% |
| Jun 30, 2017 | -2,925.72% |
| Mar 31, 2017 | -3,866.34% |
| Dec 31, 2016 | -12,405.36% |